Related Experiment Video
Updated: Jan 27, 2026

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
12.0K
Brugada Syndrome Caused by Autonomic Dysfunction in Multiple Sclerosis
Michel Ibrahim1, Garly Saint-Croix1, Rosario Colombo2
1Department of Internal Medicine, Jackson Memorial Hospital/University of Miami Hospital, Miami, FL, USA.
Case Reports in Cardiology
|March 19, 2019
Summary
Multiple sclerosis (MS) patients with Brugada pattern face syncope risks. This case explores implantable cardioverter-defibrillator (ICD) placement benefits and risks for these complex patients.
Area of Science:
- Cardiology
- Neurology
- Clinical Electrophysiology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease causing deficits like gait disturbance and balance problems, increasing fall risk.
- Autonomic dysfunction in MS can lead to falls, including those with loss of consciousness.
- Brugada pattern, a type 1 electrocardiogram (ECG) finding, is associated with syncope due to cardiac dysrhythmia.
Observation:
- A rare concurrence of multiple sclerosis and type 1 Brugada pattern presents a diagnostic and therapeutic challenge.
- Both conditions can manifest with syncopal events, albeit through different mechanisms.
- MS-related neurological deficits and autonomic dysfunction may precipitate falls, mimicking cardiac syncope.
Findings:
- The study presents a case illustrating the diagnostic and therapeutic dilemma in managing MS patients with type 1 Brugada pattern and syncopal events.
- It highlights the consideration of implantable cardioverter-defibrillators (ICDs) as a preventive measure against sudden cardiac death, similar to Brugada syndrome management.
- The case report details an approach to evaluating the risks and benefits of ICD implantation in this specific patient population.
Implications:
- This case underscores the importance of a comprehensive evaluation for both neurological and cardiac causes in MS patients experiencing syncope.
- It informs clinical decision-making regarding ICD placement in MS patients presenting with a type 1 Brugada pattern, balancing syncope prevention with procedural risks.
- Further research is warranted to establish clear guidelines for managing cardiac arrhythmias in patients with multiple sclerosis.
Related Concept Videos
Autonomic Nervous System
12.6K
The autonomic nervous system (ANS) is a critical component of the peripheral nervous system, primarily responsible for regulating involuntary bodily functions and maintaining homeostasis. It functions in tandem with the central nervous system (CNS) to seamlessly coordinate various physiological processes without the need for conscious control.
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
12.6K
Autonomic Nervous System: Overview
7.5K
The human nervous system is divided into two main parts: the central nervous system (CNS) and the peripheral nervous system (PNS). The CNS is composed of the brain and spinal cord, while the PNS contains nerve cells, clusters of nerve cells, and the sensory receptors that are outside the CNS. The PNS has two types of nerve cells: sensory (afferent) and motor (efferent). Sensory cells send signals to the CNS from receptors, and motor cells carry signals from the CNS to organs, muscles, and...
7.5K
Disorders of the Autonomic Nervous System
1.5K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
1.5K
Multiple Allele Traits
38.1K
The Concept of Multiple Allelism
38.1K
Drugs Acting on Autonomic Ganglia: Stimulants
2.1K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.1K
Drugs Acting on Autonomic Ganglia: Blockers
1.7K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.7K

